The urokinase-type plasminogen activator (uPA) plays an important role in cellular invasion. By using the downstream part of a 74 bp DNA region called the cooperation mediator (COM) of the uPA promoter as a bait sequence in the yeast one-hybrid screen, a gene called PBK1 was previously cloned from the cDNA library of the 95D lung cancer cell strain. In this study, the intracellular distribution of PBK1 was studied by using the transient transfection of pEGFP-C3-PBK1, and PBK1 was found to be localized in the nucleus. Co-transfection of pEGFP-C3-PBK1 and the deletion mutants of the pGL3-uPA promoter indicated that PBK1 can increase the uPA promoter activity by about 25% and this effect is uPA enhancer-dependent. Western blotting and Enzyme-linked immunoadsordent assay further confirmed that PBK1 can upregulate the expression of uPA. Our results suggest that PBK1 is involved in the regulation of uPA expression, which might provide a new clue to further understanding the regulation mechanism of uPA expression.
The cell behavior of the human trophoblast during embryo implantation and the subsequent process of placentation constitute an example of regulated invasiveness [1] . In contrast to this physiologically occurring invasive behavior, the invasiveness of tumor cells has escaped control mechanisms and remains unrestricted [2] . Therefore, understanding the molecular control mechanisms in physiologically invasive cells may not only provide an insight into the intact control of processes in embryogenesis, but also provide further information on the regulatory defects in tumor cells.
It has been well documented that the urokinase-type plasminogen activator (uPA) plays an important role in the degradation of the extracellular matrix and activation of other protease systems in the process of cell invasion. In situ hybridization has demonstrated the presence of uPA transcripts in the invasive trophoblast cells. Expression and activity data suggest that this protease plays a role in the process of cell invasion [3] . In addition uPA expression is higher in patients with invasive tumors compared with those with innocuous neoplasm [4] [5] [6] . Studies have shown that the expression of uPA is regulated mainly at the transcriptional level. Transcriptional regulation of the uPA gene relies upon an enhancer located at about 2 kb upstream of the transcription start site (from -1875 to -1980 bp) [7, 8] . Two elements within the enhancer have been shown to be essential for its activity: a combined PEA3/AP-1(A) site and a 74 bp downstream consensus AP-1(B) site [8, 9] . All three sites are important for uPA gene transcription induced by a variety of extracellular stimuli, such as phorbol ester, epidermal growth factor, okadaic acid, and the inactivation of any of the three sites results in the loss of enhancer function [8, 10, 11] . Synergism between PEA3/AP-1(A) and A-1(B) depends on the integrity of the 74 bp region, called the cooperation mediator (COM) , that separates these sites [11] . The COM function depends on a series of protein-binding sites, which can be recognized by the uPA enhancer factors (UEFs) that cluster in a specific bipartite upstream COM (uCOM)-downstream COM (dCOM) arrangement. When uCOM DNA is incubated with HeLa nuclear extracts, four DNA-protein complexes are formed (UEF1, UEF3-upper complex, UEF3-lower complex and UEF4) [12] . When dCOM DNA is incubated with HeLa nuclear extracts, two DNA protein complexes are formed (UEF1, UEF2) [13] . UEF3 and UEF4 have been identified [13] , and UEF1, binding to the dCOM region, has not been identified yet.
To identify the factors that bind the dCOM region in the urokinase enhancer, we screened the 95D lung cancer cell cDNA library in the yeast one-hybrid system by using a bait 5'-ATCTGGAGTCATGAGAGCT-3' from the dCOM of the uPA enhancer. We isolated a cDNA clone that was believed to be the candidate binding to the dCOM region in the urokinase enhancer. The cDNA sequence was submitted to GenBank (GenBank No. gi:3668141), and the homology was analyzed using the BLAST program, suggesting 100% homology with PBK1. The PBK1 protein appears to be an unknown protein that may be involved in the regulation of the invasiveness of trophoblast cells [14] .
Because the uPA appears to be a common mechanism used by cells to facilitate plasmin-dependent tissue invasion [15] , and PBK1 is involved in the regulation of invasion, there is an interesting correlation between PBK1 and uPA, but this correlation is still unclear.
In the present research, we determine the role of PBK1 and the relationship between PBK1 and uPA.
Materials and Methods

Materials
E. coli DH5α was used for the routine cloning. Human lung cancer cell strain 95D was purchased from the Department of Pathology, Chinese PLA General Hospital. The cDNA library of the 95D cell line was constructed by using the SMART cDNA library construction kit (Clontech, CA, USA). Restriction enzymes, T4 ligase and LA Taq DNA polymerase were all obtained from TaKaRa Limited (Dalian, China). All other chemicals were of analytical grade.
Electrophoretic mobility shift assay
Single-stranded oligonucleotides of the dCOM region (5'-ATCTGGAGTCATGAGAGCT-3', 5'-AGCTCT-CATGACTCCAGAT-3') were annealed to generate the double-stranded oligonucleotide. The ends were labeled by using T4 polynucleotide kinase and [γ-32 P]ATP. Nuclear extracts were prepared from 95D cells. 6×His-PBK1 fusion protein was expressed in E. coli BL21 transformed by pET28a(+)-PBK1 and purified by using Ni-NTA resin metal chelation chromatography (Darmstadt, Germany). The protein concentration was measured with a Bio-Rad assay using a microplate reader (Bio-Rad, CA, USA). Protein extracts (5-10 µg) were incubated on ice in a footprint buffer with or without 1 µg poly(dI-dC). [γ-32 P]ATPlabeled dCOM oligonucleotide (10,000 cpm) was added to each sample and mixed. The samples were then incubated for 20 min on ice, and resolved by electrophoresis on a 5% non-denaturing polyacrylamide gel in 0.5×TBE buffer.
PBK1 gene cloning and eukaryotic expression vector construction
Based on the sequence of its open reading frame the PBK1 gene was cloned from the cDNA library of the 95D cell line using PCR amplification with the sense primer 5'-AAGAATTCTGATGGAGGATTCGGCCTCGGCC-3' and the antisense primer 5'-ATGGATCCAAA-GGCGGCCAGGATCTGAG-3' (EcoRI and BamHI restriction sites are underlined). The PCR amplification conditions were as follows: 94 °C (30 s), 58 °C (1 min) and 72 °C (2 min), 30 cycles. The PBK1 cDNA was cloned into the eukaryotic expression vector pEGFP-C3 (Clontech) which contains the same restriction sites in its multiple cloning site. The resulting recombinant containing PBK1 cDNA was confirmed by sequencing and named pEGFP-C3-PBK1.
Transient transfection and subcellular localization of PBK1 fusion protein
95D cells were grown in RPMI 1640 medium with the addition of 10% (V/V) fetal calf serum and 100 u/ml of penicillin and 50 µg/ml of streptomycin. The expression plasmid pEGFP-C3-PBK1 was then transfected into the 95D cells. Briefly, the transient transfection of 95D cells was performed using Lipofectamine (Invitrogen, CA, USA) according to the manufacturer's instructions. Approximately 1 µg of cDNA per 150,000 cells was used in 6-well plates. In the control group, 95D cells were transfected with the pEGFP-C3. Forty-eight hours after transfection, green fluorescence was detected by using a fluorescence microscope (Olympus Japan).
Plasmid construction and luciferase activity assay
Fragments from -2350 to +30 bp of the uPA promoter were subcloned into the pGL3 vector to generate deletion mutants. The orientations and boundaries of the constructs were confirmed by restriction analysis and sequencing. The standard procedure for dual luciferase activity assay was performed according to the manufacturer's http://www.abbs.info; www.blackwellpublishing.com/abbs instructions (Promega WI, USA). The 95D cells were seeded with about 5×10 4 cells/well in 6-well plates and cultured for another 24 h. Then, the cells were cotransfected with 1 µg pEGFP-C3-PBK1 and the deletion mutants of the uPA promoter. Thirty-six hours after transfection, the transfected cells were lysed and the luciferase activity was measured.
Stable transfection and Western blotting
95D cells were transfected with pEGFP-C3-PBK1 using Lipofectamine (Gibco, CA, USA) according to the manufacturer's instructions. The cells were replated after 2 days and G418 (5 µg/ml) was added. After 2 weeks of drug selection, uniformly enhanced green fluorescent protein (EGFP)-expressing colonies were selected and further expanded. A total of 1×10 5 stable transfected 95D cells were harvested and used for Western blotting and ELISA. The cell total protein (50 µg) was separated by 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The membranes were blocked with 5% (W/V) fat-free milk and sequentially incubated with the anti-uPA antibody (Neomarkers) and anti-mouse IgG-HRP conjugated secondary antibody (Dingguo, Shanghai, China). Bands were revealed by using the SuperSignal kit (Pierce, Illinois, USA).
To prepare the cell extracts, we followed the procedure recommended by American Diagnostica Incorporated. In short, 1×10 5 cells were pulverized mechanically, then detergent extraction was used (10% Triton X-100 in 10 mM Tris-HCl buffer, pH 8.5). Centrifugation was performed at 100,000 g for 60 min at 4 °C, and the supernatant was divided into 100 µl portions. ELISA was carried out according to the manufacturer's instruction. The absorbance at 490 nm was determined using a microplate reader. All measurements were made in triplicate.
Statistical analysis
Each value is the mean±SD of three independent measurements.
Results
In vitro binding of PBK1 to the dCOM region of the uPA promoter
Electrophoresis mobility shift assay (EMSA) was carried out to check if the dCOM region of the uPA promoter was bound by the PBK1 protein. The oligonucleotide of dCOM region forms two complexes with the 95D cell nuclear extract that are specifically competed by a higher concentration (100-fold) of the unlabeled oligonucleotide. In Fig. 1 (lane 1) , the two bands indicated by arrows are the complexes formed by UEF1 and UEF2, respectively. With 6×His-PBK1 fusion protein, the oligonucleotide forms one complex that is specifically competed by a higher concentration (100-fold) of the unlabeled oligonucleotide. This complex has the same mobility as the complex formed by UEF1 (Fig. 1, lane 5) . This observation suggests that PBK1 can bind to the dCOM region in vitro, and it might be UEF1.
PBK1 gene cloning and eukaryotic expression vector construction
The full-length cDNA of PBK1 was amplified by PCR using the 95D cell line cDNA library. The PCR product was analyzed by using 1% agarose electrophoresis, and the band with the correct size was recovered from the gel and ligated into the pEGFP-C3 eukaryotic expression vector after double restriction-enzyme digestion with EcoRI and BamHI. The recombinant vector pEGFP-C3-PBK1 [ Fig. 2(A) ] was used to transform E. coli DH5α. The PCR and digestion products were analyzed by using Fig. 1 The interaction of the nuclear protein extract of 95D cells and 6×His-PBK1 fusion protein with the dCOM region of the uPA promoter in EMSA Two shifts were generated with the nuclear protein extracts of 95D cells as shown in lane 1. The 6×His-PBK1 fusion protein that binds specifically to the dCOM region is indicated by the arrow shown in lane 5.
1% agarose gel electrophoresis. As shown in Fig. 2(B) , the 1.55 kb fragment is consistent with our expectations and the fidelity of the cDNA was confirmed by sequencing (data not shown).
Transient transfection and subcellular localization of PBK1 fusion protein
To determine the cellular localization of recombinant PBK1, the expression construct pEGFP-C3-PBK1 was transfected into 95D cells, and the green fluorescence was analyzed by microscopy. As shown in Fig. 3 , the EGFP-PBK1 fusion protein was localized in the nucleus. There was no cytoplasm localization. In contrast, the control plasmid pEGFP-C3 showed a uniform distribution in both the cytoplasm and nucleus. Our data showed that PBK1 was localized in the nucleus.
dCOM-dependent upregulation effect of EGFP-PBK1 on uPA promoter activity by
Our experimental results indicated that PBK1 binds to the dCOM of uPA promoter. To assess whether the increased expression of PBK1 activates the uPA promoter, we performed a luciferase reporter gene assay. As shown in Fig. 4(A) , three deletion mutants of uPA promoter constructs, abbreviated as pGL3-uPA2350, pGL3-uPA1200 and pGL3-uPA1000, were generated. The pGL3-uPA2350 construct contained the fragment of the uPA promoter from -2350 to +30 bp, and the pGL3-uPA1200 (the pGL3-uPA1200 has enhancer and the pGL3-uPA1000 does not have enhancer) was generated by PvuII digestion and self-ligation of pGL3-uPA2350. The pGL3-uPA1000, in which the enhancer of uPA was deleted, was generated by PCR. All these constructs were co-transfected into 95D cells with pEGFP-C3-PBK1 or pEGFP-C3, and the luciferase activity was measured. As shown in Fig. 4(B) , the luciferase activity of the construct containing the enhancer of the uPA promoter was obviously induced when PBK1 was co-expressed, whereas the construct without the uPA enhancer did not respond to PBK1 overexpression. These observations indicate that overexpression of PBK1 can upregulate uPA expression at the transcriptional level and this effect is dependent on the uPA enhancer.
Overexpression of EGFP-PBK1 can upregulate uPA expression
To further investigate whether PBK1 can upregulate uPA expression, 95D cells stably transfected with pEGFP-C3-PBK1 and pEGFP-C3 respectively were lysed and analyzed by Western blotting and ELISA. As shown in Fig. 5 , uPA expression is upregulated by the overexpression of PBK1 in 95D cells. But no increase was seen in the 95D cells transfected with pEGFP-C3 and in the mock experiment. The ELISA results showed that uPA expression obviously increases in cytoplasm protein when PBK1 is overexpressed.
Discussion
uPA is involved in extracellular matrix degradation and plays an important role in the physiological and pathological processes involved in cell migration. The expres- sion of uPA is regulated on at least three levels, such as transcription, pro-enzyme activation and activity regulation by inhibitors. A number of invasive and metastatic tumors can be associated with the overexpression of the uPA (A) A series of deletions in the uPA promoter were fused to a luciferase reporter gene and were defined as pGL3-uPA2350, pGL3-uPA1200 and pGL3-uPA1000. The uPA enhancer is indicated by the black rectangle and the PvuII site is indicated by arrows. (B) The deletion mutants and pEGFP-C3-PBK1 were co-transfected into 95D cells (black bar), and the deletion mutants and pEGFP-C3 were co-transfected into 95D cells (white bar) as a control. The luciferase activity was measured and each value is the mean±SD of at least three independent experiments.
gene [16] . Many physiological or pathological stimuli activate transcription of the uPA gene [17] . Their effect is mainly mediated by the uPA enhancer, which is located approximately 2000 bp upstream of the transcriptional start site [18] and contains an AP-1(A) site at the 5' end and an AP-1(B) site at the 3' end [11] . The COM region between the AP-1 sites is necessary for the combined action of the AP-1-binding transcription factors.
Huch et al. [14] have reported that PBK1 appears to be a protein that may be involved in the mechanisms controlling proliferation, differentiation and invasiveness of trophoblast cells. It will be interesting to observe the expression of PBK1 in tumor cells and eventually to analyze its function in experiments comparing normal invasive cells (trophoblast) with abnormal (i.e. malignant) invasive cells.
In this study, we confirmed the binding of the 6×His-PBK1 fusion protein to the dCOM region of the uPA promoter. We then cloned the PBK1 gene from the cDNA library of the lung cancer cell line 95D. Transient transfection of the plasmid pEGFP-C3-PBK1 into 95D cells showed that the fusion protein EGFP-PBK1 was located in the nucleus and there was no cytoplasm localization. This result suggests that PBK1 might be a transcriptional factor. Reporter gene activity assay on the deletion mutants showed that PBK1 can increase the uPA promoter activity by about 25%. If the enhancer region is deleted, the effect of PBK1 on the uPA promoter is abrogated. That means that PBK1 upregulates uPA expression at the transcriptional level and the effect is uPA enhancer-dependent. The Western blotting and ELISA results further confirmed that the overexpression of PBK1 can upregulate the expression of uPA. It has been well documented that the COM region of the uPA promoter can form four different complexes with four distinct proteins, of which three have been identified (such as the Oct-1, Prep-1 and Pbx proteins [12] [13] [14] [19] [20] [21] ), but the fourth, UEF1, is still unknown. Because the COM region is required for full enhancer activity, it is important to identify UEF1. Our present research provides a hint as to what UEF1 may be. Further investigation is needed to determine whether PBK1 is UEF1. 
